Diffuse Large B Cell Lymphoma Relapsed
6 clinical trials · Condition
◉ Watch Diffuse Large B Cell Lymphoma Relapsed
| Record | Firm | Date |
|---|---|---|
| Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT02142049) | Pharmacyclics LLC. | 2014-05-01 |
Track Diffuse Large B Cell Lymphoma Relapsed automatically
Every clearance here is in the API, with alerts when new ones post.